comparemela.com
Home
Live Updates
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals : comparemela.com
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
MeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec for the treatment of X-linked retinitis...
Related Keywords
London ,
City Of ,
United Kingdom ,
Jason Braco ,
Lifesci Communications ,
Janssen Pharmaceuticals Inc ,
Nasdaq ,
Johnson ,
Meiragtx Holdings ,
Janssen Pharmaceuticals ,
Alexandria Forbes ,
Quality Control ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Markets ,
comparemela.com © 2020. All Rights Reserved.